| Original language | English |
|---|---|
| Pages (from-to) | e101-e102 |
| Journal | European Urology |
| Volume | 75 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 1 Apr 2019 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Boevé, L. M. S., & Vis, A. N. (2019). Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410–8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer? European Urology, 75(4), e101-e102. https://doi.org/10.1016/j.eururo.2018.11.034
Boevé, Liselotte M. S. ; Vis, André N. / Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410–8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer?. In: European Urology. 2019 ; Vol. 75, No. 4. pp. e101-e102.
@article{0df77c9d3056468ba9029de1352bf26c,
title = "Reply to Herney Andr{\'e}s Garc{\'i}a-Perdomo's Letter to the Editor re: Liselotte M.S. Boev{\'e}, Maarten C.C.M. Hulshof, Andr{\'e} N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410–8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer?",
author = "Boev{\'e}, {Liselotte M. S.} and Vis, {Andr{\'e} N.}",
year = "2019",
month = apr,
day = "1",
doi = "https://doi.org/10.1016/j.eururo.2018.11.034",
language = "English",
volume = "75",
pages = "e101--e102",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "4",
}
Boevé, LMS & Vis, AN 2019, 'Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410–8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer?', European Urology, vol. 75, no. 4, pp. e101-e102. https://doi.org/10.1016/j.eururo.2018.11.034
Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410–8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer? / Boevé, Liselotte M. S.; Vis, André N.
In: European Urology, Vol. 75, No. 4, 01.04.2019, p. e101-e102.
In: European Urology, Vol. 75, No. 4, 01.04.2019, p. e101-e102.
Research output: Contribution to journal › Letter › Academic › peer-review
TY - JOUR
T1 - Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410–8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer?
AU - Boevé, Liselotte M. S.
AU - Vis, André N.
PY - 2019/4/1
Y1 - 2019/4/1
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85062038280&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30503181
U2 - https://doi.org/10.1016/j.eururo.2018.11.034
DO - https://doi.org/10.1016/j.eururo.2018.11.034
M3 - Letter
C2 - 30503181
SN - 0302-2838
VL - 75
SP - e101-e102
JO - European Urology
JF - European Urology
IS - 4
ER -
Boevé LMS, Vis AN. Reply to Herney Andrés García-Perdomo's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol. 2019;75:410–8. High-volume Disease Has a Different Standard of Care: Is Local Treatment Really Beneficial in Low-volume Metastatic Prostate Cancer? European Urology. 2019 Apr 1;75(4):e101-e102. doi: https://doi.org/10.1016/j.eururo.2018.11.034